Target-Specific TMD Nanosheet Antagonists for Treatment of Breast Cancer
A target protein-selective transition metal dichalcogenide (TMD) nanosheet antagonist that exhibits strong binding affinity and intense Raman scattering signals for the treatment of breast cancer is designed and effectively suppressed tumor growth in vitro and in vivo, thereby enhancing the therapeutic efficacy in mice...